Carmat - executive interview with Stéphane Piat
- 174
Carmat is French biotech company that has created the first auto-regulating, bioprosthetic artificial heart able to mimic the natural physiology of the human heart.
Edison
Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisors and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations, ESG and strategic consulting. All interviews have been prepared and issued by Edison for publication globally.
View our full disclaimer - http://www.edisoninvestmentresearch.com/disclaimer/client-email-disclaimer
Edison is authorised and regulated by the Financial Conduct Authority (www.fsa.gov.uk/register/firmBasicDetails.do?sid=181584
